{"id":1783,"date":"2024-03-20T16:07:58","date_gmt":"2024-03-20T16:07:58","guid":{"rendered":"https:\/\/stoxpo.com\/?p=1783"},"modified":"2024-03-20T16:07:59","modified_gmt":"2024-03-20T16:07:59","slug":"xtl-biopharmaceuticals-announces-acquisition-of-the-social-proxy-a-strategic-move-in-ai-data-extraction","status":"publish","type":"post","link":"https:\/\/stoxpo.com\/index.php\/2024\/03\/20\/xtl-biopharmaceuticals-announces-acquisition-of-the-social-proxy-a-strategic-move-in-ai-data-extraction\/","title":{"rendered":"XTL Biopharmaceuticals Announces Acquisition of The Social Proxy: A Strategic Move in AI Data Extraction"},"content":{"rendered":"\n<p class=\"wp-block-paragraph\">Expanding Portfolio Strengthens XTL&#8217;s Position in the High-Growth Web Data Market<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">In a significant strategic move, XTL Biopharmaceuticals (XTLB) has announced its entry into a binding term sheet to acquire The Social Proxy Ltd., a leading web data company specializing in ethical, IP-based proxy and data extraction platforms for AI and BI applications. Under the agreement, XTL will acquire all issued and outstanding share capital of The Social Proxy, representing 44.6% ownership, in exchange for the issuance of XTL&#8217;s ADSs and a payment of US$430,000.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">This acquisition aligns with XTL&#8217;s strategy to bolster its asset portfolio with high-potential ventures, particularly in the burgeoning field of AI-driven data extraction. The deal includes additional warrants tied to financial milestones over the next three years, further incentivizing growth and performance.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Shlomo Shalev, CEO of XTL, expressed confidence in the acquisition&#8217;s potential to enhance shareholder value, citing the promising growth trajectory of AI web data markets. Meanwhile, Tal Kinger, CEO of The Social Proxy, emphasized the excitement of joining forces with XTL, anticipating accelerated growth and value creation under its umbrella.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Pending shareholder approval and customary closing conditions, this acquisition marks a pivotal step forward for XTL in seizing opportunities within the dynamic AI landscape.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Read original press release:<a href=\"https:\/\/finance.yahoo.com\/news\/xtl-aquire-social-proxy-141500746.html\"><mark style=\"background-color:rgba(0, 0, 0, 0)\" class=\"has-inline-color has-vivid-cyan-blue-color\">here<\/mark><\/a><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">You might like this article:<a href=\"https:\/\/stoxpo.com\/index.php\/2024\/03\/20\/trugolf-partners-with-mlspatial-to-enhance-accuracy-with-ai-powered-launch-monitor\/\"><mark style=\"background-color:rgba(0, 0, 0, 0)\" class=\"has-inline-color has-vivid-cyan-blue-color\">TruGolf Partners with mlSpatial to Enhance Accuracy with AI-Powered Launch Monitor<\/mark><\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Expanding Portfolio Strengthens XTL&#8217;s Position in the High-Growth Web Data Market In a significant strategic move, XTL Biopharmaceuticals (XTLB) has announced its entry into a binding term sheet to acquire The Social Proxy Ltd., a leading web data company specializing in ethical, IP-based proxy and data extraction platforms for AI and BI applications. Under the [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":1422,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"jnews-multi-image_gallery":[],"jnews_single_post":{"subtitle":"","format":"standard","video":"","gallery":"","source_name":"","source_url":"","via_name":"","via_url":"","override_template":"0","override":[{"template":"8","single_blog_custom":"","parallax":"1","fullscreen":"1","layout":"right-sidebar-narrow","sidebar":"author","second_sidebar":"single-right","sticky_sidebar":"1","share_position":"top","share_float_style":"share-monocrhome","show_share_counter":"0","show_view_counter":"0","show_featured":"1","show_post_meta":"1","show_post_author":"1","show_post_author_image":"1","show_post_date":"1","post_date_format":"default","post_date_format_custom":"Y\/m\/d","show_post_category":"1","show_post_reading_time":"1","post_reading_time_wpm":"300","show_zoom_button":"0","zoom_button_out_step":"2","zoom_button_in_step":"3","show_post_tag":"1","show_prev_next_post":"1","show_popup_post":"1","number_popup_post":"1","show_author_box":"1","show_post_related":"1","show_inline_post_related":"0"}],"override_image_size":"0","image_override":[{"single_post_thumbnail_size":"crop-500","single_post_gallery_size":"crop-500"}],"trending_post":"0","trending_post_position":"meta","trending_post_label":"Trending","sponsored_post":"0","sponsored_post_label":"Sponsored by","sponsored_post_name":"","sponsored_post_url":"","sponsored_post_logo_enable":"0","sponsored_post_logo":"","sponsored_post_desc":"","disable_ad":"0"},"jnews_primary_category":{"id":"","hide":""},"jnews_social_meta":{"fb_title":"","fb_description":"","fb_image":"","twitter_title":"","twitter_description":"","twitter_image":""},"jnews_override_counter":{"override_view_counter":"0","view_counter_number":"0","override_share_counter":"0","share_counter_number":"0","override_like_counter":"0","like_counter_number":"0","override_dislike_counter":"0","dislike_counter_number":"0"},"jnews_post_split":{"enable_post_split":"0","post_split":[{"template":"1","tag":"h2","numbering":"asc","mode":"normal","first":"0","enable_toc":"0","toc_type":"normal"}]},"footnotes":""},"categories":[308,358],"tags":[],"coauthors":[453],"class_list":["post-1783","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-biotechnology","category-micro-cap"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.8 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>XTL Biopharmaceuticals Announces Acquisition of The Social Proxy: A Strategic Move in AI Data Extraction - Stoxpo<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/stoxpo.com\/index.php\/2024\/03\/20\/xtl-biopharmaceuticals-announces-acquisition-of-the-social-proxy-a-strategic-move-in-ai-data-extraction\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"XTL Biopharmaceuticals Announces Acquisition of The Social Proxy: A Strategic Move in AI Data Extraction - Stoxpo\" \/>\n<meta property=\"og:description\" content=\"Expanding Portfolio Strengthens XTL&#8217;s Position in the High-Growth Web Data Market In a significant strategic move, XTL Biopharmaceuticals (XTLB) has announced its entry into a binding term sheet to acquire The Social Proxy Ltd., a leading web data company specializing in ethical, IP-based proxy and data extraction platforms for AI and BI applications. Under the [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/stoxpo.com\/index.php\/2024\/03\/20\/xtl-biopharmaceuticals-announces-acquisition-of-the-social-proxy-a-strategic-move-in-ai-data-extraction\/\" \/>\n<meta property=\"og:site_name\" content=\"Stoxpo\" \/>\n<meta property=\"article:published_time\" content=\"2024-03-20T16:07:58+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2024-03-20T16:07:59+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/stoxpo.com\/wp-content\/uploads\/2024\/02\/pexels-mart-production-7088524-scaled.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"2560\" \/>\n\t<meta property=\"og:image:height\" content=\"1707\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Liliana Vida\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Liliana Vida\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/stoxpo.com\\\/index.php\\\/2024\\\/03\\\/20\\\/xtl-biopharmaceuticals-announces-acquisition-of-the-social-proxy-a-strategic-move-in-ai-data-extraction\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/stoxpo.com\\\/index.php\\\/2024\\\/03\\\/20\\\/xtl-biopharmaceuticals-announces-acquisition-of-the-social-proxy-a-strategic-move-in-ai-data-extraction\\\/\"},\"author\":{\"name\":\"Liliana Vida\",\"@id\":\"https:\\\/\\\/stoxpo.com\\\/#\\\/schema\\\/person\\\/db8b371dfcaa698eaedb5afa5e713fb1\"},\"headline\":\"XTL Biopharmaceuticals Announces Acquisition of The Social Proxy: A Strategic Move in AI Data Extraction\",\"datePublished\":\"2024-03-20T16:07:58+00:00\",\"dateModified\":\"2024-03-20T16:07:59+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/stoxpo.com\\\/index.php\\\/2024\\\/03\\\/20\\\/xtl-biopharmaceuticals-announces-acquisition-of-the-social-proxy-a-strategic-move-in-ai-data-extraction\\\/\"},\"wordCount\":240,\"publisher\":{\"@id\":\"https:\\\/\\\/stoxpo.com\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/stoxpo.com\\\/index.php\\\/2024\\\/03\\\/20\\\/xtl-biopharmaceuticals-announces-acquisition-of-the-social-proxy-a-strategic-move-in-ai-data-extraction\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/stoxpo.com\\\/wp-content\\\/uploads\\\/2024\\\/02\\\/pexels-mart-production-7088524-scaled.jpg\",\"articleSection\":[\"Biotechnology\",\"Micro-Cap\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/stoxpo.com\\\/index.php\\\/2024\\\/03\\\/20\\\/xtl-biopharmaceuticals-announces-acquisition-of-the-social-proxy-a-strategic-move-in-ai-data-extraction\\\/\",\"url\":\"https:\\\/\\\/stoxpo.com\\\/index.php\\\/2024\\\/03\\\/20\\\/xtl-biopharmaceuticals-announces-acquisition-of-the-social-proxy-a-strategic-move-in-ai-data-extraction\\\/\",\"name\":\"XTL Biopharmaceuticals Announces Acquisition of The Social Proxy: A Strategic Move in AI Data Extraction - Stoxpo\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/stoxpo.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/stoxpo.com\\\/index.php\\\/2024\\\/03\\\/20\\\/xtl-biopharmaceuticals-announces-acquisition-of-the-social-proxy-a-strategic-move-in-ai-data-extraction\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/stoxpo.com\\\/index.php\\\/2024\\\/03\\\/20\\\/xtl-biopharmaceuticals-announces-acquisition-of-the-social-proxy-a-strategic-move-in-ai-data-extraction\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/stoxpo.com\\\/wp-content\\\/uploads\\\/2024\\\/02\\\/pexels-mart-production-7088524-scaled.jpg\",\"datePublished\":\"2024-03-20T16:07:58+00:00\",\"dateModified\":\"2024-03-20T16:07:59+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/stoxpo.com\\\/index.php\\\/2024\\\/03\\\/20\\\/xtl-biopharmaceuticals-announces-acquisition-of-the-social-proxy-a-strategic-move-in-ai-data-extraction\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/stoxpo.com\\\/index.php\\\/2024\\\/03\\\/20\\\/xtl-biopharmaceuticals-announces-acquisition-of-the-social-proxy-a-strategic-move-in-ai-data-extraction\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/stoxpo.com\\\/index.php\\\/2024\\\/03\\\/20\\\/xtl-biopharmaceuticals-announces-acquisition-of-the-social-proxy-a-strategic-move-in-ai-data-extraction\\\/#primaryimage\",\"url\":\"https:\\\/\\\/stoxpo.com\\\/wp-content\\\/uploads\\\/2024\\\/02\\\/pexels-mart-production-7088524-scaled.jpg\",\"contentUrl\":\"https:\\\/\\\/stoxpo.com\\\/wp-content\\\/uploads\\\/2024\\\/02\\\/pexels-mart-production-7088524-scaled.jpg\",\"width\":2560,\"height\":1707,\"caption\":\"radiology-2\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/stoxpo.com\\\/index.php\\\/2024\\\/03\\\/20\\\/xtl-biopharmaceuticals-announces-acquisition-of-the-social-proxy-a-strategic-move-in-ai-data-extraction\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/stoxpo.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"XTL Biopharmaceuticals Announces Acquisition of The Social Proxy: A Strategic Move in AI Data Extraction\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/stoxpo.com\\\/#website\",\"url\":\"https:\\\/\\\/stoxpo.com\\\/\",\"name\":\"Stoxpo\",\"description\":\"Stock Market &amp; Financial News\",\"publisher\":{\"@id\":\"https:\\\/\\\/stoxpo.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/stoxpo.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/stoxpo.com\\\/#organization\",\"name\":\"Stoxpo\",\"url\":\"https:\\\/\\\/stoxpo.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/stoxpo.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/stoxpo.com\\\/wp-content\\\/uploads\\\/2024\\\/02\\\/4q4p91-LogoMakr.png\",\"contentUrl\":\"https:\\\/\\\/stoxpo.com\\\/wp-content\\\/uploads\\\/2024\\\/02\\\/4q4p91-LogoMakr.png\",\"width\":250,\"height\":250,\"caption\":\"Stoxpo\"},\"image\":{\"@id\":\"https:\\\/\\\/stoxpo.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/stoxpo.com\\\/#\\\/schema\\\/person\\\/db8b371dfcaa698eaedb5afa5e713fb1\",\"name\":\"Liliana Vida\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/68bef66f029f68660c9d513c7abee60cc2c1cc99a1c80c13e95592bed4296cfd?s=96&d=mm&r=ga2a6b2037962b89d9d0225f04f06bac6\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/68bef66f029f68660c9d513c7abee60cc2c1cc99a1c80c13e95592bed4296cfd?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/68bef66f029f68660c9d513c7abee60cc2c1cc99a1c80c13e95592bed4296cfd?s=96&d=mm&r=g\",\"caption\":\"Liliana Vida\"},\"description\":\"Liliana is a seasoned financial journalist with enthusiasm for unraveling the complexities of market fluctuations and identifying paradigm-shifting trends within the stock market landscape. With years of experience in covering the stock market and publicly traded companies, Liliana has honed her skills in turning press releases into concise, informative articles. For tips and inquiries, reach out to Liliana at tips@stoxpo.com.\",\"url\":\"https:\\\/\\\/stoxpo.com\\\/index.php\\\/author\\\/stoxpo-com\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"XTL Biopharmaceuticals Announces Acquisition of The Social Proxy: A Strategic Move in AI Data Extraction - Stoxpo","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/stoxpo.com\/index.php\/2024\/03\/20\/xtl-biopharmaceuticals-announces-acquisition-of-the-social-proxy-a-strategic-move-in-ai-data-extraction\/","og_locale":"en_US","og_type":"article","og_title":"XTL Biopharmaceuticals Announces Acquisition of The Social Proxy: A Strategic Move in AI Data Extraction - Stoxpo","og_description":"Expanding Portfolio Strengthens XTL&#8217;s Position in the High-Growth Web Data Market In a significant strategic move, XTL Biopharmaceuticals (XTLB) has announced its entry into a binding term sheet to acquire The Social Proxy Ltd., a leading web data company specializing in ethical, IP-based proxy and data extraction platforms for AI and BI applications. Under the [&hellip;]","og_url":"https:\/\/stoxpo.com\/index.php\/2024\/03\/20\/xtl-biopharmaceuticals-announces-acquisition-of-the-social-proxy-a-strategic-move-in-ai-data-extraction\/","og_site_name":"Stoxpo","article_published_time":"2024-03-20T16:07:58+00:00","article_modified_time":"2024-03-20T16:07:59+00:00","og_image":[{"width":2560,"height":1707,"url":"https:\/\/stoxpo.com\/wp-content\/uploads\/2024\/02\/pexels-mart-production-7088524-scaled.jpg","type":"image\/jpeg"}],"author":"Liliana Vida","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Liliana Vida","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/stoxpo.com\/index.php\/2024\/03\/20\/xtl-biopharmaceuticals-announces-acquisition-of-the-social-proxy-a-strategic-move-in-ai-data-extraction\/#article","isPartOf":{"@id":"https:\/\/stoxpo.com\/index.php\/2024\/03\/20\/xtl-biopharmaceuticals-announces-acquisition-of-the-social-proxy-a-strategic-move-in-ai-data-extraction\/"},"author":{"name":"Liliana Vida","@id":"https:\/\/stoxpo.com\/#\/schema\/person\/db8b371dfcaa698eaedb5afa5e713fb1"},"headline":"XTL Biopharmaceuticals Announces Acquisition of The Social Proxy: A Strategic Move in AI Data Extraction","datePublished":"2024-03-20T16:07:58+00:00","dateModified":"2024-03-20T16:07:59+00:00","mainEntityOfPage":{"@id":"https:\/\/stoxpo.com\/index.php\/2024\/03\/20\/xtl-biopharmaceuticals-announces-acquisition-of-the-social-proxy-a-strategic-move-in-ai-data-extraction\/"},"wordCount":240,"publisher":{"@id":"https:\/\/stoxpo.com\/#organization"},"image":{"@id":"https:\/\/stoxpo.com\/index.php\/2024\/03\/20\/xtl-biopharmaceuticals-announces-acquisition-of-the-social-proxy-a-strategic-move-in-ai-data-extraction\/#primaryimage"},"thumbnailUrl":"https:\/\/stoxpo.com\/wp-content\/uploads\/2024\/02\/pexels-mart-production-7088524-scaled.jpg","articleSection":["Biotechnology","Micro-Cap"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/stoxpo.com\/index.php\/2024\/03\/20\/xtl-biopharmaceuticals-announces-acquisition-of-the-social-proxy-a-strategic-move-in-ai-data-extraction\/","url":"https:\/\/stoxpo.com\/index.php\/2024\/03\/20\/xtl-biopharmaceuticals-announces-acquisition-of-the-social-proxy-a-strategic-move-in-ai-data-extraction\/","name":"XTL Biopharmaceuticals Announces Acquisition of The Social Proxy: A Strategic Move in AI Data Extraction - Stoxpo","isPartOf":{"@id":"https:\/\/stoxpo.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/stoxpo.com\/index.php\/2024\/03\/20\/xtl-biopharmaceuticals-announces-acquisition-of-the-social-proxy-a-strategic-move-in-ai-data-extraction\/#primaryimage"},"image":{"@id":"https:\/\/stoxpo.com\/index.php\/2024\/03\/20\/xtl-biopharmaceuticals-announces-acquisition-of-the-social-proxy-a-strategic-move-in-ai-data-extraction\/#primaryimage"},"thumbnailUrl":"https:\/\/stoxpo.com\/wp-content\/uploads\/2024\/02\/pexels-mart-production-7088524-scaled.jpg","datePublished":"2024-03-20T16:07:58+00:00","dateModified":"2024-03-20T16:07:59+00:00","breadcrumb":{"@id":"https:\/\/stoxpo.com\/index.php\/2024\/03\/20\/xtl-biopharmaceuticals-announces-acquisition-of-the-social-proxy-a-strategic-move-in-ai-data-extraction\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/stoxpo.com\/index.php\/2024\/03\/20\/xtl-biopharmaceuticals-announces-acquisition-of-the-social-proxy-a-strategic-move-in-ai-data-extraction\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/stoxpo.com\/index.php\/2024\/03\/20\/xtl-biopharmaceuticals-announces-acquisition-of-the-social-proxy-a-strategic-move-in-ai-data-extraction\/#primaryimage","url":"https:\/\/stoxpo.com\/wp-content\/uploads\/2024\/02\/pexels-mart-production-7088524-scaled.jpg","contentUrl":"https:\/\/stoxpo.com\/wp-content\/uploads\/2024\/02\/pexels-mart-production-7088524-scaled.jpg","width":2560,"height":1707,"caption":"radiology-2"},{"@type":"BreadcrumbList","@id":"https:\/\/stoxpo.com\/index.php\/2024\/03\/20\/xtl-biopharmaceuticals-announces-acquisition-of-the-social-proxy-a-strategic-move-in-ai-data-extraction\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/stoxpo.com\/"},{"@type":"ListItem","position":2,"name":"XTL Biopharmaceuticals Announces Acquisition of The Social Proxy: A Strategic Move in AI Data Extraction"}]},{"@type":"WebSite","@id":"https:\/\/stoxpo.com\/#website","url":"https:\/\/stoxpo.com\/","name":"Stoxpo","description":"Stock Market &amp; Financial News","publisher":{"@id":"https:\/\/stoxpo.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/stoxpo.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/stoxpo.com\/#organization","name":"Stoxpo","url":"https:\/\/stoxpo.com\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/stoxpo.com\/#\/schema\/logo\/image\/","url":"https:\/\/stoxpo.com\/wp-content\/uploads\/2024\/02\/4q4p91-LogoMakr.png","contentUrl":"https:\/\/stoxpo.com\/wp-content\/uploads\/2024\/02\/4q4p91-LogoMakr.png","width":250,"height":250,"caption":"Stoxpo"},"image":{"@id":"https:\/\/stoxpo.com\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/stoxpo.com\/#\/schema\/person\/db8b371dfcaa698eaedb5afa5e713fb1","name":"Liliana Vida","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/68bef66f029f68660c9d513c7abee60cc2c1cc99a1c80c13e95592bed4296cfd?s=96&d=mm&r=ga2a6b2037962b89d9d0225f04f06bac6","url":"https:\/\/secure.gravatar.com\/avatar\/68bef66f029f68660c9d513c7abee60cc2c1cc99a1c80c13e95592bed4296cfd?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/68bef66f029f68660c9d513c7abee60cc2c1cc99a1c80c13e95592bed4296cfd?s=96&d=mm&r=g","caption":"Liliana Vida"},"description":"Liliana is a seasoned financial journalist with enthusiasm for unraveling the complexities of market fluctuations and identifying paradigm-shifting trends within the stock market landscape. With years of experience in covering the stock market and publicly traded companies, Liliana has honed her skills in turning press releases into concise, informative articles. For tips and inquiries, reach out to Liliana at tips@stoxpo.com.","url":"https:\/\/stoxpo.com\/index.php\/author\/stoxpo-com\/"}]}},"_links":{"self":[{"href":"https:\/\/stoxpo.com\/index.php\/wp-json\/wp\/v2\/posts\/1783","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/stoxpo.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/stoxpo.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/stoxpo.com\/index.php\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/stoxpo.com\/index.php\/wp-json\/wp\/v2\/comments?post=1783"}],"version-history":[{"count":1,"href":"https:\/\/stoxpo.com\/index.php\/wp-json\/wp\/v2\/posts\/1783\/revisions"}],"predecessor-version":[{"id":1785,"href":"https:\/\/stoxpo.com\/index.php\/wp-json\/wp\/v2\/posts\/1783\/revisions\/1785"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/stoxpo.com\/index.php\/wp-json\/wp\/v2\/media\/1422"}],"wp:attachment":[{"href":"https:\/\/stoxpo.com\/index.php\/wp-json\/wp\/v2\/media?parent=1783"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/stoxpo.com\/index.php\/wp-json\/wp\/v2\/categories?post=1783"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/stoxpo.com\/index.php\/wp-json\/wp\/v2\/tags?post=1783"},{"taxonomy":"author","embeddable":true,"href":"https:\/\/stoxpo.com\/index.php\/wp-json\/wp\/v2\/coauthors?post=1783"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}